Adults don't need tetanus, diphtheria boosters if fully vaccinated as children
India’s COVID-19 vaccination coverage has crossed 181.52 Crore (1,81,52,45,644) today. More than 27 lakh (27,07,127) Vaccine Doses have been administered till 7 pm today. More than 32 lakh (32,36,418) vaccine doses have been administered to 12-14 years age group so far. More than 2.18 Crore(2,18,70,591) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.
The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:
Cumulative Vaccine Dose Coverage
HCWs
1st Dose
10403109
2nd Dose
9991646
Precaution Dose
4368728
FLWs
1st Dose
18412239
2nd Dose
17490715
Precaution Dose
6683104
Age Group 12-14 years
1st Dose
3236418
Age Group 15-18 years
1st Dose
56286476
2nd Dose
35781567
Age Group 18-44 years
1st Dose
553865292
2nd Dose
460121989
Age Group 45-59 years
1st Dose
202625134
2nd Dose
183938763
Over 60 years
1st Dose
126651525
2nd Dose
114570180
Precaution Dose
10818759
Cumulative 1st dose administered
971480193
Cumulative 2nd dose administered
821894860
Precaution Dose
21870591
Total
1815245644
Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:
Date: 21st March, 2022 (430th Day)
HCWs
1st Dose
60
2nd Dose
888
Precaution Dose
8951
FLWs
1st Dose
65
2nd Dose
1572
Precaution Dose
16431
Age Group 12-14 years
1st Dose
1430043
Age Group 15-18 years
1st Dose
70024
2nd Dose
247277
Age Group 18-44 years
1st Dose
68142
2nd Dose
542149
Age Group 45-59 years
1st Dose
10106
2nd Dose
127042
Over 60 years
1st Dose
6830
2nd Dose
82305
Precaution Dose
95242
Cumulative 1st dose administered
1585270
Cumulative 2nd dose administered
1001233
Precaution Dose
120624
Total
2707127
The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.